WPRIM Management System> DCMS> Chinese Journal of Urology> 2022> 43> 1

Volume: 43 Issue: 1

1. Intelligent medicine: a new journey for urologists Page:1—4
2. Efficacy comparison of robot-assisted partial nephrectomy and laparoscopic partial nephrectomy in the treatment of giant renal angiomyolipoma Page:5—9
3. Monitoring of sunitinib blood concentration and analysis of its safety and efficacy in Chinese patients with metastatic renal cell carcinoma Page:10—16
4. Preoperative Nomogram prediction model for lymph node metastasis in patients with renal cell carcinoma Page:17—22
5. Robot-assisted retrohepatic inferior vena cava tumor thrombectomy in treating renal tumor with a single position: initial series Page:23—27
6. Effect of different HER2 expression on the efficacy of immunotherapy for advanced urothelial carcinoma who failed the previous chemotherapy Page:28—34
7. Risk factor analysis of patients with biochemical recurrence after radical prostatectomy Page:35—39
8. Comparison of 18F-PSMA PET/CT and mpMRI in the diagnosis of pelvic lymph node metastasis of prostate cancer Page:40—45
9. Study on influencing factors of clinically significant prostate cancer in PI-RADS 3 patients Page:46—50
10. Trend analysis of the incidence of prostate cancer in cancer registration areas of China between 1988 and 2015 Page:51—55
11. The abnormalities of free uroflow curve in female patients with detrusor underactivity and their clinical significance Page:56—61
12. Diagnosis and treatment of congenital anterior urethrocutaneous fistula Page:62—66
13. Effect of extract of livistona chinensis on the proliferation and apoptosis of bladder cancer cells and its related mechanisms Page:67—72
14. A case report of bladder malakoplakia in systemic sclerosis patient Page:73—74
15. The research progress in surgical treatment of primary hyperaldosteronism Page:75—78

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.